COMPASS+
COMPASS+ is a behavioral intervention with 9 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
Compass 3: A Novel Transition Program to Reduce Disability After Stroke
A Novel Transition Program to Reduce Disability After Stroke
Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study
Clinical Trials (9)
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
Compass 3: A Novel Transition Program to Reduce Disability After Stroke
A Novel Transition Program to Reduce Disability After Stroke
Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study
Assessing the Acceptability and Feasibility of COMPASS
COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic
Creating Opportunities Through Mentoring, Parenting and Safe Spaces - Democratic Republic of Congo
Creating Opportunities Through Mentoring, Parental Involvement and Safe Spaces - Ethiopia
All 9 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 9